BioChem - DOS

Metabolic engineering of Escherichia coli for α-farnesene production

Metabolic engineering

Wang, Chonglong; Yoon, Sang-Hwal; Jang, Hui-Jeong; Chung, Young-Ryun; Kim, Jae-Yean; Choi, Eui-Sung; Kim, Seon-Won

<P><B>Abstract</B></P><P>Sesquiterpenes are important materials in pharmaceuticals and industry. Metabolic engineering has been successfully used to produce these valuable compounds in microbial hosts. However, the microbial potential of sesquiterpene production is limited by the poor heterologous expression of plant sesquiterpene synthases and the deficient FPP precursor supply. In this study, we engineered <I>E. coli</I> to produce &#x003B1;-farnesene using a codon-optimized &#x003B1;-farnesene synthase and an exogenous MVA pathway. Codon optimization of &#x003B1;-farnesene synthase improved both the synthase expression and &#x003B1;-farnesene production. Augmentation of the metabolic flux for FPP synthesis conferred a 1.6- to 48.0-fold increase in &#x003B1;-farnesene production. An additional increase in &#x003B1;-farnesene production was achieved by the protein fusion of FPP synthase and &#x003B1;-farnesene synthase. The engineered <I>E. coli</I> strain was able to produce 380.0mg/L of &#x003B1;-farnesene, which is an approximately 317-fold increase over the initial production of 1.2mg/L.</P> <P><B>Highlights</B></P><P>&#x025BA; Codon optimization of &#x003B1;-farnesene synthase improved &#x003B1;-farnesene production. &#x025BA; Insufficient supply of IPP and DMAPP limited &#x003B1;-farnesene production. &#x025BA; Augmentation of metabolic flux for FPP synthesis increased &#x003B1;-farnesene production. &#x025BA; FPP flux was directed to &#x003B1;-farnesene synthesis by protein fusion. &#x025BA; Intermediates accumulation limited further increase of &#x003B1;-farnesene production.</P>

2011

1096-7176

1096-7184

13

6

pp.648-655

10.1016/j.ymben.2011.08.001

http://click.ndsl.kr/servlet/OpenAPIDetailView?keyValue=05787966&target=NART&cn=NART57889861

&#x003B1; -Farnesene; FPP synthesis; Mevalonate pathway; Codon optimization; Protein fusion;